Water-filtered Infrared-A Radiation in Patients With Hand Osteoarthritis

Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Mar 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment called water-filtered Infrared-A radiation to see if it can help reduce pain and improve movement in patients with hand osteoarthritis. Osteoarthritis is a condition that causes joint pain and stiffness, particularly in the fingers. Researchers want to find out if this treatment can make a difference in how much pain patients feel and how well they can use their hands over time. They will also compare the results of those receiving the treatment to individuals who are on a wait-list, to see if those receiving the treatment are happier with their results.

To participate in this trial, patients need to be aged between 65 and 74 and have a confirmed diagnosis of finger osteoarthritis, with pain occurring for more than half of the day for the past three months. They should rate their pain as more than 4 on a scale of 0 to 10 in the last 24 hours. It's important that they do not have any other serious joint diseases or health issues that would interfere with the study. Participants will attend sessions where they will receive the treatment and will be asked about their pain levels and daily activities. This trial is currently looking for volunteers to help us learn more about this potential new therapy for hand osteoarthritis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of finger polyarthritis (confirmed by a specialist, radiological findings available)
• • Local pain for more than 50% of the day in the past 3 months.
• • Subjective pain intensity of local pain in the last 24 hours on a VAS scale of 0 to 10 being \>4.
• • No planned local treatment in the next 6 months.
• • No planned intra-articular injections within the next 6 months.
• • The patient must be able to understand the study explanations and appropriately follow the instructions of the investigating physician.
• Exclusion Criteria:
• • Chronic inflammatory joint diseases.
• • Poor general health.
• • Febrile diseases.
• • Fibromyalgia syndrome.
• • Psychotic disorders.
• • Severe comorbidities.
• • Acute unclear skin diseases.
• • Heat urticaria.
• • Painful diseases/diagnoses of the shoulder and/or arm.
• • Lymphatic vessel diseases (lymphedema, lymphangitis).
• • Porphyria.
• • Pain-associated diseases/diagnoses of the shoulder and/or arm.
• • Intra-articular injections or arthroscopies within the last 3 months.
• • Previous or planned surgical procedure on the affected joints in the last 8 weeks or in the upcoming 6 months.
• • Intake or application of photosensitizing drugs or extracts (e.g., porphyrins, tetracyclines, sulfonamides, psoralenes, St. John's wort).
• • Systemic medication with glucocorticoids or immunosuppressants.
• • Pain medication with opioid analgesics.
• • Known pregnancy.
• • Concurrent participation in another clinical trial.